PWPS
ANIK icon

Pinnacle Wealth Planning Services’s Anika Therapeutics ANIK Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-172
Closed -$8K – 426
2020
Q4 		$8K Buy
+172
New +$6.53K ﹤0.01% 1454

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $18.1B AUM 18.25% 1-Year Est. Return

Pinnacle Wealth Planning Services's ANIK Position: Q1 2021 in Review

Pinnacle Wealth Planning Services sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 172 shares — an estimated $8K sold.

Pinnacle Wealth Planning Services first reported a position in ANIK in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 146 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

  • Pinnacle Wealth Planning Services reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Pinnacle Wealth Planning Services sold 172 Anika Therapeutics shares in Q1 2021, an estimated $8K.
  • Pinnacle Wealth Planning Services first reported a position in Anika Therapeutics in Q4 2020 and held it in 1 quarter.
  • Pinnacle Wealth Planning Services's Anika Therapeutics position peaked at $8K in Q4 2020.
  • 146 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2021, filed 29 Apr 2021.